BACKGROUND: Colorectal cancer (CRC) screening reduces the mortality due to CRC. It is important for health care providers to be aware of the variation in the products available for CRC screening. PURPOSE: The purpose of this study was to summarize the accuracy of results of individual fecal immunochemical test (FIT) products across pathology proficiency testing programs. METHODS: Secondary data analysis of proficiency testing programs' FIT results. RESULTS: Four of 7 proficiency testing program's FIT evaluations were obtained for a 2-year period. Fourteen unique FIT brands were evaluated by at least 1 of the 4 proficiency testing programs. Five of the products performed similarly with sensitivities ranging from 98.1% to 98.8% and specificities from 98.1% to 99.6%. Ninety-three percent of the FIT tests completed were manual Clinical Laboratory Improvement Amendments-waived FITs. CONCLUSIONS: About two thirds of the commonly used FIT products performed acceptably on spiked samples of human hemoglobin. However, some had low sensitivity and specificity and probably should not be used for population-based or other screening. Further investigation to determine appropriate, reliable products for fecal occult blood testing is warranted.
BACKGROUND:Colorectal cancer (CRC) screening reduces the mortality due to CRC. It is important for health care providers to be aware of the variation in the products available for CRC screening. PURPOSE: The purpose of this study was to summarize the accuracy of results of individual fecal immunochemical test (FIT) products across pathology proficiency testing programs. METHODS: Secondary data analysis of proficiency testing programs' FIT results. RESULTS: Four of 7 proficiency testing program's FIT evaluations were obtained for a 2-year period. Fourteen unique FIT brands were evaluated by at least 1 of the 4 proficiency testing programs. Five of the products performed similarly with sensitivities ranging from 98.1% to 98.8% and specificities from 98.1% to 99.6%. Ninety-three percent of the FIT tests completed were manual Clinical Laboratory Improvement Amendments-waived FITs. CONCLUSIONS: About two thirds of the commonly used FIT products performed acceptably on spiked samples of human hemoglobin. However, some had low sensitivity and specificity and probably should not be used for population-based or other screening. Further investigation to determine appropriate, reliable products for fecal occult blood testing is warranted.
Entities:
Keywords:
colorectal cancer screening; fecal immunochemical test (FIT); fecal occult blood test (FOBT); proficiency testing programs
Authors: Barcey T Levy; Jeanette M Daly; Bruce Luxon; Mary L Merchant; Yinghui Xu; Carly E Levitz; Jason K Wilbur Journal: J Prim Care Community Health Date: 2010-04-01
Authors: Michael B Potter; Judith M E Walsh; Tina M Yu; Ginny Gildengorin; Lawrence W Green; Stephen J McPhee Journal: Am J Prev Med Date: 2011-07 Impact factor: 5.043
Authors: Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Moshe Leshno; Yaron Niv Journal: Ann Intern Med Date: 2007-02-20 Impact factor: 25.391
Authors: James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby Journal: J Natl Cancer Inst Date: 2007-09-25 Impact factor: 13.506
Authors: Leo G M van Rossum; Anne F van Rijn; Martijn G H van Oijen; Paul Fockens; Robert J F Laheij; Andre L M Verbeek; Jan B M J Jansen; Evelien Dekker Journal: Int J Cancer Date: 2009-08-15 Impact factor: 7.396
Authors: Barcey T Levy; Jeanette M Daly; Yinghui Xu; Seth D Crockett; Richard M Hoffman; Jeffrey D Dawson; Kim Parang; Navkiran K Shokar; Daniel S Reuland; Marc J Zuckerman; Avraham Levin Journal: Contemp Clin Trials Date: 2021-05-08 Impact factor: 2.261
Authors: Ni Ni Moe Myint; Ajay M Verma; Daniel Fernandez-Garcia; Panchali Sarmah; Patrick S Tarpey; Saif Sattar Al-Aqbi; Hong Cai; Ricky Trigg; Kevin West; Lynne M Howells; Anne Thomas; Karen Brown; David S Guttery; Baljit Singh; Howard J Pringle; Ultan McDermott; Jacqui A Shaw; Alessandro Rufini Journal: Cell Death Dis Date: 2018-08-30 Impact factor: 8.469